Quantum Biopharma Ltd (QNTM) Stock Price, Quote & News

Company Profile

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. It operates through two segments, Biopharmaceutical Innovation and Strategic Investments. The company researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. Its lead compound is Lucid-MS, a patented new chemical entity that is...

Industry: Biotechnology

Sector: Healthcare

Phone: 833 571 1811

Website: www.quantumbiopharma.com

Address:

55 University Avenue, Suite 1003, Toronto, Canada

Redman70 Sep. 8 at 12:37 AM

$QNTM That 13 G filing that Malone is referring to has an effective date in June if I’m not mistaken? If he still owns that many, then I would think the 13G he filed last week would not be as of june. seems fishy to me. I’d love to see a current filing on him regarding his QNTM holdings.

0 · Reply

sunkissed1 Sep. 7 at 2:38 PM

$GNS $QNTM soon GNS will get that 13G 🤞🏻

2 · Reply

nealp89 Sep. 7 at 2:08 PM

$GNS everyone is blocking Kevin on X I mean I don’t blame them,all Kevin does is talk meanwhile we tanking every fucking day and $QNTM and his 13g is no where to be found

1 · Reply

FickleFin Sep. 7 at 12:49 PM

$QNTM 📉

0 · Reply

Night_Owl_Biotech Sep. 7 at 2:32 AM

Just for fun, the attachment lists the top 25 one-day gains in bio stocks YTD. Gains ranged from 105 to 788%. It shows the changes 1 week later, 4 weeks later & through last Friday's close 9/5/25. Roughly 2 of every 3 stocks fell the following week after the big gain, 4 weeks later & through last Friday. The higher the market cap the day before the big gain the lower the risk of future losses. $CRVO & $QNTM share prices hung in there despite the low market cap (versus their peers) though QNTM has been steadily heading lower lately. $ABVX $CELC & $CDTX clearly bucked the trend versus their peers. We focus on commercial-stage bio so no disrespect. We do not follow any of the 3. DRRX is excluded because its gain was due to M&A Again this post is just for fun. It is possible This is not investment advice.

0 · Reply

GB1156 Sep. 6 at 1:56 AM

$QNTM I will buy at bottom. I had great loss experience.

0 · Reply

jtcdub Sep. 5 at 8:01 PM

$QNTM Added 75 shares before the bell.

0 · Reply

Cons228 Sep. 5 at 2:17 PM

$QNTM nothing to see here …

0 · Reply

SomeNothingBurgers Sep. 5 at 1:56 PM

$QNTM daaaamn

0 · Reply

Ml95 Sep. 4 at 5:59 PM

$QNTM if this stock is as manipulated as they say, the price could be being manipulated to be brought down to hit stop losses, or until people have enough and sell their positions. malone mentioned in his x call yesterday that there are no shares when someone asked a question regarding his DWAC being reversed. in other words people own shares that technically do not exist and the market makers must push them out or expose their own manipulation.

1 · Reply

Quantum BioPharma Announces Update to Previously Announced Private Placement

Aug 11, 2025, 7:40 AM EDT - 27 days ago

Quantum BioPharma Signs Agreement to Manufacture Oral Drug Formulation of its Potential Breakthrough Drug Lucid-21-302 (Lucid-MS) for Use in its Upcoming Phase 2 Multiple Sclerosis Trial

Aug 8, 2025, 8:00 AM EDT - 4 weeks ago

Quantum BioPharma Announces Very Promising Results from the Massachusetts General Hospital Scientists on the Novel Positron Emission Tomography (PET) Tracer Used to Detect and Monitor Demyelination in Multiple Sclerosis Patients

Aug 7, 2025, 7:00 AM EDT - 4 weeks ago

Quantum Biopharma Reports Strong Second Quarter with Increased Current and Total Assets, Conversion of all Debentures into Equity, Continued Exclusion of Going Concern, Tripling of Share Price during Quarter, over $500,000 USD Gain in Crypto Assets as of date of filing, and Near Elimination of Debt

Aug 5, 2025, 7:34 AM EDT - 4 weeks ago

Quantum Biopharma Announces Positive Results of the Clinical Study Report (CSR) for the Phase 1 Multiple Ascending Dose (MAD) Clinical Trial of Experimental Multiple Sclerosis Drug Lucid-21-302 (Lucid-MS)

Aug 4, 2025, 7:33 AM EDT - 4 weeks ago

Quantum BioPharma Files Reply and Provides Update on Court Case Seeking Damages Against CIBC, RBC and Others in Excess of $700,000,000 USD for Possible Stock Price Manipulation/Spoofing

Jul 31, 2025, 7:24 AM EDT - 5 weeks ago

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Commences Reg D Capital Raise Campaign to Fund Growth and Possible IPO

Jul 30, 2025, 4:00 PM EDT - 5 weeks ago

Quantum BioPharma Shares' Rollercoaster Day: What's Going On?

Jul 22, 2025, 7:00 AM EDT - 6 weeks ago

Quantum BioPharma Makes Strategic Investment in GameStop Corp.

GME

Jun 27, 2025, 4:30 PM EDT - 2 months ago

Quantum BioPharma Announces Private Placement

Jun 26, 2025, 7:30 AM EDT - 2 months ago

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Launches $5 Million Reg D Capital Raise to Fund Growth and Path to Possible Initial Public Offering

Jun 18, 2025, 9:19 AM EDT - 2 months ago

Singular Research Reports on Quantum BioPharma Ltd.'s Strategic Advances and Pipeline Progress

Jun 17, 2025, 8:00 AM EDT - 2 months ago

Quantum BioPharma Announces First Person with Multiple Sclerosis (MS) Scanned in Joint Study with Massachusetts General Hospital

Jun 13, 2025, 7:00 AM EDT - 3 months ago

Quantum BioPharma Announces Intention to Declare Special Dividend of Contingent Value Rights (CVRs) Linked to Future Litigation Settlement Proceeds

Jun 3, 2025, 7:50 AM EDT - 3 months ago

Quantum BioPharma Clarifies It Has Not Changed Its Name

Jun 2, 2025, 1:47 PM EDT - 3 months ago

iNGENū CRO Partners with Quantum BioPharma to Launch Pioneering Australian Clinical Trial for Chronic Nociplastic Pain in MCAS Patients

May 30, 2025, 7:00 AM EDT - 3 months ago

Quantum BioPharma Receives $2.35 Million USD from a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari

May 29, 2025, 7:30 AM EDT - 3 months ago

Quantum Biopharma Licensee Celly Nutrition Retains Leading Audit Firm MNP LLP to Advance Capital Raise and Go-Public Readiness and Changes Name To Unbuzzd Wellness Inc.

May 28, 2025, 8:00 AM EDT - 3 months ago

Quantum BioPharma Receives Ethics Committee Approval for Phase 2 Clinical Trial of FSD202 for Nociplastic Pain in Patients with Idiopathic Mast Cell Activation Syndrome

May 20, 2025, 7:30 AM EDT - 3 months ago

Quantum Biopharma Announces Signing of an Agreement with a Global Pharmaceutical Contract Research Organization to Prepare an IND (Investigational New Drug) Application Package for Lucid-21-302 (Lucid-MS), A First-In-Class Treatment for Multiple Sclerosis

May 19, 2025, 7:30 AM EDT - 3 months ago

Quantum Biopharma Purchases an Additional USD $1 Million of Bitcoin and Other Cryptocurrencies to Hold BTC Treasury and To Generate Staking Revenue. Bringing the Total Investment in Digital Assets to USD $4,500,000

May 16, 2025, 7:30 AM EDT - 4 months ago

Quantum BioPharma to Attend Sidoti Micro-Cap Investor Conference and the AGP Virtual Healthcare Conference

May 12, 2025, 8:00 AM EDT - 4 months ago

Quantum BioPharma Announces Completion of Dosing in 90-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-MS for Multiple Sclerosis

May 6, 2025, 8:25 PM EDT - 4 months ago

Quantum BioPharma Ltd. (QNTM) Business Update Conference Call Transcript

May 5, 2025, 7:08 AM EDT - 4 months ago

Quantum Biopharma Files Amended Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing

Apr 24, 2025, 7:00 AM EDT - 4 months ago

Quantum BioPharma to Host Business Update Conference Call on Tuesday, May 6, 2025 at 4:30 p.m. Eastern Time

Apr 22, 2025, 7:00 AM EDT - 4 months ago

Quantum Biopharma Announces Advocate Against Naked Short Selling and Stock Manipulation, Kevin Malone Appointed as Board Advisor

Apr 18, 2025, 8:00 PM EDT - 5 months ago

Quantum BioPharma Corporate Update

Apr 14, 2025, 7:30 AM EDT - 5 months ago

Quantum Biopharma Wins Reconsideration Motion by Dr. Raza Bokhari at the Court of Appeal for Ontario

Apr 3, 2025, 7:00 AM EDT - 5 months ago

Quantum BioPharma Licensee Celly Nutrition Launches unbuzzd in Puerto Rico

Apr 1, 2025, 2:00 AM EDT - 5 months ago

Quantum BioPharma Announces Joint Clinical Study With Massachusetts General Hospital Scientists to Validate a Novel Positron Emission Tomography (PET) Imaging Technique to Monitor Demyelination In Multiple Sclerosis

Mar 31, 2025, 7:00 AM EDT - 5 months ago

Quantum Biopharma Announces Closing of Final $2.42 Million Tranche of $5 Million Total Financing on Improved Terms

Mar 30, 2025, 7:00 PM EDT - 5 months ago

Quantum BioPharma Provides Corporate Update

Mar 28, 2025, 4:38 PM EDT - 5 months ago

Overlooked Stock: QNTM

Mar 28, 2025, 9:15 AM EDT - 5 months ago

Quantum Biopharma's 2024 Financial Statements Show Strong Improvements in Cash, Working Capital, Operating Efficiency and the Removal of Material Uncertainty Related to Going Concern

Mar 20, 2025, 7:30 AM EDT - 6 months ago

Quantum BioPharma Continues to Grow Its Crypto Assets and Diversify Its Treasury With the Purchase of Another USD $1,500,000 Worth of Bitcoin (BTC) and Other Cryptocurrencies

Mar 17, 2025, 3:33 PM EDT - 6 months ago

Quantum BioPharma Unaware of Any Material Change

Feb 11, 2025, 7:30 AM EST - 7 months ago

Quantum Biopharma Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program

Feb 10, 2025, 7:30 AM EST - 7 months ago

Quantum Biopharma Engages Enterprise Canada and Empire Market Ventures to Lead Public Communications and Investor Awareness Programs

Feb 6, 2025, 7:30 AM EST - 7 months ago

Quantum Biopharma Licensee Celly Nutrition Retains Leading New York Investment Bank to Advise on Capital Raise and Possible Initial Public Offering Following Highly Positive Results from unbuzzd™ Clinical Study

Feb 4, 2025, 7:03 AM EST - 7 months ago

Quantum Biopharma Announces the Success of unbuzzd™ Clinical Trial

Jan 17, 2025, 7:30 AM EST - 8 months ago

Quantum Biopharma in Court With Dr. Raza Bokhari on January 24, 2025 Seeking a Court Order to Declare Him to Be a Vexatious Litigant and Other Litigation Updates

Jan 14, 2025, 8:30 AM EST - 8 months ago

Quantum Biopharma Ltd. Now Trading on Upstream Under QNTM

Jan 7, 2025, 8:30 AM EST - 8 months ago

Quantum Biopharma Ltd. Approved to Dual List on Upstream

Dec 20, 2024, 7:30 PM EST - 9 months ago

Quantum Biopharma Announces Closing of Second Tranche

Dec 20, 2024, 9:15 AM EST - 9 months ago

Quantum Biopharma Diversifies Treasury With the Purchase of USD $1,000,000 of Bitcoin (BTC) and Other Cryptocurrencies and to Allow for Future Financings and Other Transactions in Cryptocurrency

Dec 20, 2024, 7:30 AM EST - 9 months ago

Quantum BioPharma Diversifies Treasury with the Purchase of USD $1,000,000 of Bitcoin (BTC) and Other Cryptocurrencies and to Allow for Future Financings and Other Transactions in Cryptocurrency

Dec 13, 2024, 7:00 PM EST - 9 months ago

Quantum Biopharma Announces Closing of First Tranche

Dec 10, 2024, 7:30 AM EST - 9 months ago

Quantum Biopharma Announces That the Safety Review Committee Recommends Commencing Dosing of Second Cohort in the Phase 1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-MS)

Dec 5, 2024, 7:30 AM EST - 9 months ago

Quantum Biopharma Announces Non-Brokered Private Placement of Convertible Debenture Units for Gross Proceeds of Up to $5 Million

Redman70 Sep. 8 at 12:37 AM

0 · Reply

sunkissed1 Sep. 7 at 2:38 PM

$GNS $QNTM soon GNS will get that 13G 🤞🏻

2 · Reply

nealp89 Sep. 7 at 2:08 PM

$GNS everyone is blocking Kevin on X I mean I don’t blame them,all Kevin does is talk meanwhile we tanking every fucking day and $QNTM and his 13g is no where to be found

1 · Reply

FickleFin Sep. 7 at 12:49 PM

$QNTM 📉

0 · Reply

Night_Owl_Biotech Sep. 7 at 2:32 AM

0 · Reply

GB1156 Sep. 6 at 1:56 AM

$QNTM I will buy at bottom. I had great loss experience.

0 · Reply

jtcdub Sep. 5 at 8:01 PM

$QNTM Added 75 shares before the bell.

0 · Reply

Cons228 Sep. 5 at 2:17 PM

$QNTM nothing to see here …

0 · Reply

SomeNothingBurgers Sep. 5 at 1:56 PM

$QNTM daaaamn

0 · Reply

Ml95 Sep. 4 at 5:59 PM

1 · Reply

NoFearHere Sep. 4 at 5:38 PM

$QNTM stoploss out when fell below that trendline The 200 dma @ 11.13 is only support seen

0 · Reply

Wannaride Sep. 4 at 4:51 PM

$QNTM Some free advice for people who want to invest their money in a growing company. Take a look at companies that have complained about naked shorts. Find the ratio of successful investments to ones which were not successful. I think you'll find that whatever the truth of the matter is, the odds do not favor those who invest based on the thesis.

0 · Reply

unaboomer Sep. 4 at 4:10 PM

$QNTM well, have to say I trusted Malone but I no longer do unless miraculously things turn around, won’t matter to me as I’ve cashed out . Malone et all have had more than enough time really nothing legally has happened and despite the pump it looks obvious nothing will happen. Kevin’s more than welcome to say different, but he won’t. If anything, pumping stupid live streams with NOTHING to say, just made $QNTM tank even further and I don’t think the bottom is here, it’s gonna keep dropping. If Malone and QNTM expect investors to stand behind them then they should be providing proper updates, to me this all played out like a classic pump and dump.

0 · Reply

Kindah Sep. 4 at 4:03 PM

$QNTM wrf is going over here 😖 Fml with this stupid investment strategy that i have! I just keep buying pos scam stocks that doesn’t even have a community!! Malone we know you bought very cheap but come on

0 · Reply

FickleFin Sep. 4 at 12:20 PM

$QNTM stock is DEAD. Malone PLAYED everyone... Zeeshan QUIET. Same SPOOF SToRY/NAkED SHORTS being told that is a DEAD HORSE. Same pumpers. Different aliases. The ones pumping are BOD and friends. Compensation goes nowhere except the pockets of the BOD. AI posts by agoracom are stupid (3rd paid party) everyone gets paid or compensated to pump stock. REAPER @u on X make all valid points. Milestones haven't been met. In Feb Jason Sawyer interview with stocktwits stated RTD were coming. Nothing after that. UNBUZZD fell off... Sales suck. Nothing from Kevin, Gerry David, or John Duffy. If you ran or backed a company you would be proud to show face. They just recycle quotes from pre unbzzd promo days(Waiting for IPO) 😒 Company has been patting themselves on the back but for what. They never reach dated milestones. Phase 2 for MS has been due. They have made a profit off their crypto investment but I'm sure it wasnt re invested into company. Always a loophole and a charade.

0 · Reply

Learningtoretire Sep. 3 at 8:14 PM

$GNS malone hasnt said a thing in a week about GNS or $QNTM Wonder why the silence

3 · Reply

makedatbread88 Sep. 3 at 5:45 PM

$QNTM bottom is in

1 · Reply

sumon89 Sep. 3 at 5:22 AM

$AMC in a way it is . On the surface AA dose his best , but behind the spot light's he doesn't. All of us see that the stock is massively manipulated and all of us can back him up if he would take cort action. Other company's have done it like $QNTM . Now 🤔 ...what if the bord is paid in stock share just to put in a nice filling of selling when the stock starts to rise so they can kill the algorithm, same way they did every time with the share conversion. I really hope to bag on this one soon .

0 · Reply

Mark_Venture Sep. 2 at 8:39 PM

$QNTM and $NGENF are the future of MS and neurological condition treatment. Chen Lin thinks NervGen could even be the next Eli Lilly.

4 · Reply

TalkMarkets Sep. 2 at 7:31 PM

From Hype To Hardware: What Investors Need To Know About #QuantumComputing $QNTM https://talkmarkets.com/content/stocks--equities/from-hype-to-hardware-what-investors-need-to-know-about-quantum-computing?post=519707

1 · Reply

okalternative Sep. 2 at 4:22 PM

$QNTM This stock will pop 💥🚀

2 · Reply

LicketySplitz03 Sep. 2 at 2:59 PM

$QNTM ⏰ over 17.80 we climbing. 😎

0 · Reply

Market Cap	53.63M
Revenue (ttm)	0.00
Net Income (ttm)	-14.20M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	117,600
Avg Vol	175,790
Day's Range	N/A - N/A
Shares Out	3.82M
Stochastic %K	7%
Beta	0.77
Analysts	Sell
Price Target	$35.50